{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:57:14Z","timestamp":1781539034319,"version":"3.54.5"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Improving health status, including symptoms and quality of life, is a key goal in the management of atrial fibrillation (AF). However, whether improvements in patient-reported health status are associated with subsequent clinical outcomes remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the association between changes in health status and long-term adverse clinical outcomes in patients with AF.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study used data from a prospective multicenter registry in Japan that enrolled patients aged 22 to 94 years with newly diagnosed AF or who were newly referred for AF management between September 20, 2012, and May 22, 2018. The registry collected follow-up data for up to 5 years. Eligible patients completed the Atrial Fibrillation Effect on Quality of Life patient-reported outcome measure (PROM) questionnaire at both baseline and 1-year follow-up. Clinical outcomes were assessed for 4 years following the 1-year AF PROM assessment. Data were analyzed between February 7 and July 14, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n One-year change in the AF PROM overall summary score.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was a composite of all-cause death, heart failure hospitalization, and stroke or transient ischemic attack over 4 years. Multivariable hierarchical regression models adjusted for baseline score, clinical factors, and comorbidities were used to evaluate associations between 1-year change in AF PROM overall summary score and outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 2744 patients (mean [SD] age, 67.8 [11.1] years; 1868 male [68.1%]; 1357 [49.6%] with paroxysmal AF), 1408 (51.3%) had improved health status (overall summary score increase of \u22655 points), 833 (30.4%) had stable health status, and 503 (18.3%) had worsened health status (overall summary score decrease of \u22655 points). During a mean (SD) follow-up of 3.1 (1.4) years after the 1-year assessment, the primary outcome occurred in 283 patients (10.3%). After adjustment for baseline characteristics (including baseline AF PROM score), improvement in the AF PROM overall summary score was associated with a lower risk of adverse outcomes (per 5-point increase: hazard ratio, 0.93 [95% CI, 0.89-0.96];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cohort study of patients with AF in Japan found that greater improvements in 1-year AF PROM scores were associated with a lower risk of subsequent adverse clinical events. These findings support the prognostic value of PROMs and highlight the importance of monitoring health status in AF management.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.17776","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:40Z","timestamp":1781537440000},"page":"e2617776","source":"Crossref","is-referenced-by-count":0,"title":["Health Status Changes and Long-Term Clinical Outcomes in Patients With Atrial Fibrillation"],"prefix":"10.1001","volume":"9","author":[{"given":"Takanori","family":"Ohata","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Ikemura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"},{"name":"Saint Luke\u2019s Mid America Heart Institute, Kansas City, Missouri"},{"name":"University of Missouri\u2013Kansas City\u2019s Healthcare Institute for Innovations in Quality, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Chan","sequence":"additional","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, Kansas City, Missouri"},{"name":"University of Missouri\u2013Kansas City\u2019s Healthcare Institute for Innovations in Quality, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nakamaru","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine, Kyorin University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Katsumata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwao","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hino Municipal Hospital, Hino, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Saitama Hospital, Wako, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takatsuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, Kansas City, Missouri"},{"name":"University of Missouri\u2013Kansas City\u2019s Healthcare Institute for Innovations in Quality, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ieda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"10","key":"zoi260503r1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"zoi260503r2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"zoi260503r3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.","volume":"36","author":"Dorian","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"zoi260503r4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/heartjnl-2011-300550","article-title":"Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry.","volume":"98","author":"Steg","year":"2012","journal-title":"Heart"},{"issue":"1","key":"zoi260503r5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"zoi260503r6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"36","key":"zoi260503r7","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"13","key":"zoi260503r8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: The CABANA randomized clinical trial.","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"issue":"47","key":"zoi260503r9","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1093\/eurheartj\/ehaa658","article-title":"Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial.","volume":"41","author":"Haldar","year":"2020","journal-title":"Eur Heart J"},{"issue":"23","key":"zoi260503r10","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial.","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"issue":"9","key":"zoi260503r11","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.jacep.2023.05.037","article-title":"Baseline health status and its association with subsequent cardiovascular events in patients with atrial fibrillation.","volume":"9","author":"Ikemura","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"zoi260503r12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamacardio.2017.3983","article-title":"Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials.","volume":"2","author":"Pokharel","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"20","key":"zoi260503r14","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"zoi260503r15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032746","article-title":"Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).","volume":"9","author":"Ikemura","year":"2019","journal-title":"BMJ Open"},{"issue":"5","key":"zoi260503r16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005358","article-title":"Defining clinically important difference in the atrial fibrillation effect on quality-of-life score.","volume":"12","author":"Holmes","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"zoi260503r17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamacardio.2016.0529","article-title":"Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF registry.","volume":"1","author":"Piccini","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"38","key":"zoi260503r18","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.","volume":"37","author":"Bassand","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi260503r19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ehjqcco\/qcab028","article-title":"GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.","volume":"8","author":"Fox","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"12","key":"zoi260503r20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/eurheartj\/ehw565","article-title":"A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.","volume":"38","author":"Fanola","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi260503r21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11739-015-1326-1","article-title":"Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score.","volume":"11","author":"Pastori","year":"2016","journal-title":"Intern Emerg Med"},{"issue":"5","key":"zoi260503r22","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.amjcard.2012.04.049","article-title":"A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation.","volume":"110","author":"Suzuki","year":"2012","journal-title":"Am J Cardiol"},{"issue":"12","key":"zoi260503r23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1177\/2047487313500568","article-title":"Cumulative impact of axial, structural, and repolarization ECG findings on long-term cardiovascular mortality among healthy individuals in Japan: National Integrated Project for Prospective Observation of Non-Communicable Disease and its Trends in the Aged, 1980 and 1990.","volume":"21","author":"Inohara","year":"2014","journal-title":"Eur J Prev Cardiol"},{"issue":"15","key":"zoi260503r24","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1161\/CIRCULATIONAHA.106.670901","article-title":"Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.","volume":"115","author":"Kosiborod","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"zoi260503r25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"zoi260503r26","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/STROKEAHA.121.035796","article-title":"Long-term cognitive decline after stroke: an individual participant data meta-analysis.","volume":"53","author":"Lo","year":"2022","journal-title":"Stroke"},{"issue":"1","key":"zoi260503r27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33375","article-title":"Functional ability and health problems of stroke survivors: an explorative study.","volume":"15","author":"Poomalai","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"zoi260503r28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/STROKEAHA.122.041502","article-title":"Poststroke disability: association between sex and patient-reported outcomes.","volume":"54","author":"Oliveira","year":"2023","journal-title":"Stroke"},{"issue":"24","key":"zoi260503r29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010498","article-title":"Gender differences in patient-reported outcomes among adults with atherosclerotic cardiovascular disease.","volume":"7","author":"Okunrintemi","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"zoi260503r30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ejhf.1299","article-title":"Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.","volume":"21","author":"Luo","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"zoi260503r31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial.","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"zoi260503r32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation.","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi260503r33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation.","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"zoi260503r34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation.","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"issue":"22","key":"zoi260503r35","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.124.069624","article-title":"Clinical impact of routine assessment of patient-reported health status in heart failure clinic: the PRO-HF trial.","volume":"149","author":"Sandhu","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"zoi260503r36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMp1611252","article-title":"Patient-reported outcomes - harnessing patients\u2019 voices to improve clinical care.","volume":"376","author":"Basch","year":"2017","journal-title":"N Engl J Med"},{"key":"zoi260503r13","unstructured":"Keio University School of Medicine, Department of Cardiology. Keio Interhospital Cardiovascular Studies\u2013Atrial Fibrillation Registry. University Hospital Medical Information Network of Japan identifier UMIN000022229. Updated April 30, 2020. Accessed May 8, 2025. https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000025601"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850249\/ohata_2026_oi_260503_1780688426.1979.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:43Z","timestamp":1781537443000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.17776","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}